Overview

Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery

Status:
Unknown status
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that the antifibrinolytic drugs aprotinin and tranexamic acid equally influence bleeding tendency and transfusion requirement in patients undergoing first time cardiac procedures with a low risk of increased postoperative bleeding.Only patients undergoing first time CABG or first time aortic valve replacement are included in this study.
Phase:
Phase 3
Details
Lead Sponsor:
German Heart Center
Treatments:
Aprotinin
Tranexamic Acid